NextFin News - Jim Cramer’s Charitable Trust initiated a new position in Intel on Wednesday, purchasing 400 shares at approximately $114 per share following a sharp 12% technical pullback. The move, executed shortly after the opening bell on June 3, 2026, marks a strategic bet on the "CPU renaissance" within data centers and the revitalization of Intel’s foundry business under the leadership of CEO Lip-Bu Tan. The trust funded the acquisition using cash reserves from recent sales of Broadcom, Corning, and Wells Fargo, establishing an initial 1.10% weighting for the chipmaker in its portfolio.
The decision to buy follows a five-session slide where Intel shares dropped from $123.52 to $107.93. This decline was largely attributed to market jitters during Nvidia’s Computex conference, where the AI giant unveiled a new PC processor. However, Jeff Marks, director of portfolio analysis for the CNBC Investing Club, argues that the sell-off presents a buying opportunity. Marks, who supports Cramer’s charitable trust, has historically maintained a constructive view on diversified semiconductor plays, focusing on infrastructure shifts rather than just GPU dominance. He notes that while Nvidia’s GPUs remain the gold standard for AI training, the industry is shifting toward "agentic AI" systems that demand significantly more central processing unit (CPU) power.
According to Intel CEO Lip-Bu Tan, the architectural requirements for AI server racks are evolving rapidly. In the early stages of the AI boom, the ratio of hardware was typically one CPU for every eight GPUs. As the industry moves from model training to inference and multi-agent workloads, that ratio has tightened to one CPU for every four GPUs. Tan, who took the helm in March 2025 and has been credited with narrowing Intel's strategic focus, suggested in a recent interview that the ratio could eventually reach parity. This perspective is gaining traction among some industry observers who believe agentic workloads—where AI "agents" perform complex, multi-step tasks—will favor the versatile processing capabilities of high-end CPUs.
Beyond the data center, Intel’s foundry business is emerging as a critical alternative to Taiwan Semiconductor Manufacturing Co. (TSMC), which is currently operating near full capacity. Intel CFO David Zinsner recently characterized the company’s previous struggles as "trying to fly the plane and fix the wing at the same time," referring to the manufacturing delays and low yields that plagued the firm before 2025. The narrative has since shifted; Intel recently secured a preliminary deal with Apple to produce specialized chips and has been tapped by Elon Musk for his $119 billion "Terafab" project in Austin, Texas. Musk’s venture is expected to utilize Intel’s future 14A chip node process, which Tan expects to reach volume production by 2029.
Despite the optimism from the Investing Club, this bullish stance on Intel is not yet a consensus view on Wall Street. Many analysts remain cautious, citing the immense capital expenditure required to compete with TSMC and the risk that Intel’s 18A and 14A processes may still face execution hurdles. While the trust has set a price target of $140, the investment remains a "scenario-based" play on the successful turnaround of Intel’s manufacturing arm and the sustained growth of agentic AI. If manufacturing yields fail to meet Apple’s or Tesla’s stringent requirements, the projected recovery in Intel’s market share could stall, leaving the stock vulnerable to further volatility in a highly competitive semiconductor landscape.
Explore more exclusive insights at nextfin.ai.
